FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097277023> ?p ?o ?g. }

• W2097277023 endingPage "1018" @default.
• W2097277023 startingPage "1014" @default.
• W2097277023 abstract "Vascular endothelial growth factor (VEGF)-A is overexpressed in most malignant and premalignant breast lesions. VEGF-A can be visualized noninvasively with PET imaging and using the tracer (89)Zr-labeled bevacizumab. In this clinical feasibility study, we assessed whether VEGF-A in primary breast cancer can be visualized by (89)Zr-bevacizumab PET.Before surgery, breast cancer patients underwent a PET/CT scan of the breasts and axillary regions 4 d after intravenous administration of 37 MBq of (89)Zr-bevacizumab per 5 mg. PET images were compared with standard imaging modalities. (89)Zr-bevacizumab uptake was quantified as the maximum standardized uptake value (SUV max). VEGF-A levels in tumor and normal breast tissues were assessed with enzyme-linked immunosorbent assay. Data are presented as mean ± SD.Twenty-five of 26 breast tumors (mean size ± SD, 25.1 ± 19.8 mm; range, 4-80 mm) in 23 patients were visualized. SUV max was higher in tumors (1.85 ± 1.22; range, 0.52-5.64) than in normal breasts (0.59 ± 0.37; range, 0.27-1.69; P < 0.001). The only tumor not detected on PET was 10 mm in diameter. Lymph node metastases were present in 10 axillary regions; 4 could be detected with PET (SUV max, 2.66 ± 2.03; range, 1.32-5.68). VEGF-A levels in the 17 assessable tumors were higher than in normal breast tissue in all cases (VEGF-A/mg protein, 184 ± 169 pg vs. 10 ± 21 pg; P = 0.001), whereas (89)Zr-bevacizumab tumor uptake correlated with VEGF-A tumor levels (r = 0.49).VEGF-A in primary breast cancer can be visualized by means of (89)Zr-bevacizumab PET." @default.
• W2097277023 created "2016-06-24" @default.
• W2097277023 creator A5001423670 @default.
• W2097277023 creator A5007632268 @default.
• W2097277023 creator A5011165801 @default.
• W2097277023 creator A5024217960 @default.
• W2097277023 creator A5028689548 @default.
• W2097277023 creator A5033364484 @default.
• W2097277023 creator A5044616361 @default.
• W2097277023 creator A5058800375 @default.
• W2097277023 creator A5061236216 @default.
• W2097277023 creator A5061575449 @default.
• W2097277023 creator A5067253176 @default.
• W2097277023 creator A5072881153 @default.
• W2097277023 creator A5077189629 @default.
• W2097277023 creator A5088754136 @default.
• W2097277023 date "2013-05-07" @default.
• W2097277023 modified "2023-10-05" @default.
• W2097277023 title "⁸⁹Zr-Bevacizumab PET Imaging in Primary Breast Cancer" @default.
• W2097277023 cites W1946385338 @default.
• W2097277023 cites W1964920016 @default.
• W2097277023 cites W1967438857 @default.
• W2097277023 cites W1967651806 @default.
• W2097277023 cites W1976056487 @default.
• W2097277023 cites W1981989535 @default.
• W2097277023 cites W1995587606 @default.
• W2097277023 cites W2041323004 @default.
• W2097277023 cites W2046507292 @default.
• W2097277023 cites W2049810993 @default.
• W2097277023 cites W2058723907 @default.
• W2097277023 cites W2082356023 @default.
• W2097277023 cites W2082786039 @default.
• W2097277023 cites W2083307394 @default.
• W2097277023 cites W2083642576 @default.
• W2097277023 cites W2083793124 @default.
• W2097277023 cites W2100265880 @default.
• W2097277023 cites W2116818526 @default.
• W2097277023 cites W2132893003 @default.
• W2097277023 cites W2134120544 @default.
• W2097277023 cites W2145187086 @default.
• W2097277023 cites W2153982924 @default.
• W2097277023 cites W2162719553 @default.
• W2097277023 cites W2240380290 @default.
• W2097277023 cites W4293247451 @default.
• W2097277023 doi "https://doi.org/10.2967/jnumed.112.117218" @default.
• W2097277023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23651946" @default.
• W2097277023 hasPublicationYear "2013" @default.
• W2097277023 type Work @default.
• W2097277023 sameAs 2097277023 @default.
• W2097277023 citedByCount "140" @default.
• W2097277023 countsByYear W20972770232013 @default.
• W2097277023 countsByYear W20972770232014 @default.
• W2097277023 countsByYear W20972770232015 @default.
• W2097277023 countsByYear W20972770232016 @default.
• W2097277023 countsByYear W20972770232017 @default.
• W2097277023 countsByYear W20972770232018 @default.
• W2097277023 countsByYear W20972770232019 @default.
• W2097277023 countsByYear W20972770232020 @default.
• W2097277023 countsByYear W20972770232021 @default.
• W2097277023 countsByYear W20972770232022 @default.
• W2097277023 countsByYear W20972770232023 @default.
• W2097277023 crossrefType "journal-article" @default.
• W2097277023 hasAuthorship W2097277023A5001423670 @default.
• W2097277023 hasAuthorship W2097277023A5007632268 @default.
• W2097277023 hasAuthorship W2097277023A5011165801 @default.
• W2097277023 hasAuthorship W2097277023A5024217960 @default.
• W2097277023 hasAuthorship W2097277023A5028689548 @default.
• W2097277023 hasAuthorship W2097277023A5033364484 @default.
• W2097277023 hasAuthorship W2097277023A5044616361 @default.
• W2097277023 hasAuthorship W2097277023A5058800375 @default.
• W2097277023 hasAuthorship W2097277023A5061236216 @default.
• W2097277023 hasAuthorship W2097277023A5061575449 @default.
• W2097277023 hasAuthorship W2097277023A5067253176 @default.
• W2097277023 hasAuthorship W2097277023A5072881153 @default.
• W2097277023 hasAuthorship W2097277023A5077189629 @default.
• W2097277023 hasAuthorship W2097277023A5088754136 @default.
• W2097277023 hasBestOaLocation W20972770231 @default.
• W2097277023 hasConcept C121608353 @default.
• W2097277023 hasConcept C126322002 @default.
• W2097277023 hasConcept C142724271 @default.
• W2097277023 hasConcept C167734588 @default.
• W2097277023 hasConcept C199374082 @default.
• W2097277023 hasConcept C2775842073 @default.
• W2097277023 hasConcept C2775930923 @default.
• W2097277023 hasConcept C2776694085 @default.
• W2097277023 hasConcept C2777025900 @default.
• W2097277023 hasConcept C2777802072 @default.
• W2097277023 hasConcept C2780849966 @default.
• W2097277023 hasConcept C2989005 @default.
• W2097277023 hasConcept C530470458 @default.
• W2097277023 hasConcept C71924100 @default.
• W2097277023 hasConceptScore W2097277023C121608353 @default.
• W2097277023 hasConceptScore W2097277023C126322002 @default.
• W2097277023 hasConceptScore W2097277023C142724271 @default.
• W2097277023 hasConceptScore W2097277023C167734588 @default.
• W2097277023 hasConceptScore W2097277023C199374082 @default.
• W2097277023 hasConceptScore W2097277023C2775842073 @default.
• W2097277023 hasConceptScore W2097277023C2775930923 @default.

• next